img

Global and United States Irritable Bowel Syndrome Treatment Drug Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Irritable Bowel Syndrome Treatment Drug Market Report & Forecast 2024-2034

Irritable bowel syndrome (IBS) is a common condition that affects the digestive system. It causes symptoms like stomach cramps, bloating, diarrhoea and constipation. These tend to come and go over time, and can last for days, weeks or months at a time. It's usually a lifelong problem.
Market Analysis and InsightsGlobal and United States Irritable Bowel Syndrome Treatment Drug Market
This report focuses on global and United States Irritable Bowel Syndrome Treatment Drug market, also covers the segmentation data of other regions in regional level and county level.
The global Irritable Bowel Syndrome Treatment Drug revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the review period (2024-2034).
In United States the Irritable Bowel Syndrome Treatment Drug revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period 2024-2034.
The global key players of Irritable Bowel Syndrome Treatment Drug include Abbvie Inc., Bristol Myers Squibb, Roche, Johnson & Johnson, Pfizer Inc., Prometheus Laboratories Inc. (Nestle), Bausch Health, Takeda Pharmaceutical Ltd and Biogen, etc. The global five biggest players hold a share of % in 2024.
Global Irritable Bowel Syndrome Treatment Drug Scope and Market Size
Irritable Bowel Syndrome Treatment Drug market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Irritable Bowel Syndrome Treatment Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For United States market, this report focuses on the Irritable Bowel Syndrome Treatment Drug market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Abbvie Inc.
Bristol Myers Squibb
Roche
Johnson & Johnson
Pfizer Inc.
Prometheus Laboratories Inc. (Nestle)
Bausch Health
Takeda Pharmaceutical Ltd
Biogen
AstraZeneca
Segment by Type
Antibiotics
Amino Salicylates
Corticosteroids
Immunomodulators
Others

Segment by Application


Hospitals
Specialty Clinics
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Irritable Bowel Syndrome Treatment Drug definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Irritable Bowel Syndrome Treatment Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Irritable Bowel Syndrome Treatment Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Irritable Bowel Syndrome Treatment Drug revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Irritable Bowel Syndrome Treatment Drug Product Introduction
1.2 Global Irritable Bowel Syndrome Treatment Drug Outlook 2018 VS 2024 VS 2034
1.2.1 Global Irritable Bowel Syndrome Treatment Drug Market Size for the Year 2018-2034
1.2.2 United States Irritable Bowel Syndrome Treatment Drug Market Size for the Year 2018-2034
1.3 Irritable Bowel Syndrome Treatment Drug Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of United States Irritable Bowel Syndrome Treatment Drug in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Irritable Bowel Syndrome Treatment Drug Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4 Irritable Bowel Syndrome Treatment Drug Market Dynamics
1.4.1 Irritable Bowel Syndrome Treatment Drug Industry Trends
1.4.2 Irritable Bowel Syndrome Treatment Drug Market Drivers
1.4.3 Irritable Bowel Syndrome Treatment Drug Market Challenges
1.4.4 Irritable Bowel Syndrome Treatment Drug Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Irritable Bowel Syndrome Treatment Drug by Type
2.1 Irritable Bowel Syndrome Treatment Drug Market Segment by Type
2.1.1 Antibiotics
2.1.2 Amino Salicylates
2.1.3 Corticosteroids
2.1.4 Immunomodulators
2.1.5 Others
2.2 Global Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018, 2024 & 2034)
2.3 Global Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018-2034)
2.4 United States Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018, 2024 & 2034)
2.5 United States Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018-2034)
3 Irritable Bowel Syndrome Treatment Drug by Application
3.1 Irritable Bowel Syndrome Treatment Drug Market Segment by Application
3.1.1 Hospitals
3.1.2 Specialty Clinics
3.1.3 Other
3.2 Global Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018, 2024 & 2034)
3.3 Global Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018-2034)
3.4 United States Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018, 2024 & 2034)
3.5 United States Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018-2034)
4 Global Irritable Bowel Syndrome Treatment Drug Competitor Landscape by Company
4.1 Global Irritable Bowel Syndrome Treatment Drug Market Size by Company
4.1.1 Global Key Companies of Irritable Bowel Syndrome Treatment Drug, Ranked by Revenue (2024)
4.1.2 Global Irritable Bowel Syndrome Treatment Drug Revenue by Player (2018-2023)
4.2 Global Irritable Bowel Syndrome Treatment Drug Concentration Ratio (CR)
4.2.1 Irritable Bowel Syndrome Treatment Drug Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Irritable Bowel Syndrome Treatment Drug in 2024
4.2.3 Global Irritable Bowel Syndrome Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Irritable Bowel Syndrome Treatment Drug Head office and Area Served
4.4 Global Key Players of Irritable Bowel Syndrome Treatment Drug, Product and Application
4.5 Global Key Players of Irritable Bowel Syndrome Treatment Drug, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Irritable Bowel Syndrome Treatment Drug Market Size by Company
4.7.1 Key Players of Irritable Bowel Syndrome Treatment Drug in United States, Ranked by Revenue (2024)
4.7.2 United States Irritable Bowel Syndrome Treatment Drug Revenue by Players (2021, 2024 & 2023)
5 Global Irritable Bowel Syndrome Treatment Drug Market Size by Region
5.1 Global Irritable Bowel Syndrome Treatment Drug Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Irritable Bowel Syndrome Treatment Drug Market Size by Region (2018-2034)
5.2.1 Global Irritable Bowel Syndrome Treatment Drug Market Size by Region: 2018-2023
5.2.2 Global Irritable Bowel Syndrome Treatment Drug Market Size by Region (2024-2034)
6 Americas
6.1 Americas Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth 2018-2034
6.2 Americas Irritable Bowel Syndrome Treatment Drug Market Size by Type
6.2.1 Americas Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018-2023)
6.2.2 Americas Irritable Bowel Syndrome Treatment Drug Market Size by Type (2024-2034)
6.2.3 Americas Irritable Bowel Syndrome Treatment Drug Market Share by Type (2018-2034)
6.3 Americas Irritable Bowel Syndrome Treatment Drug Market Size by Application
6.3.1 Americas Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018-2023)
6.3.2 Americas Irritable Bowel Syndrome Treatment Drug Market Size by Application (2024-2034)
6.3.3 Americas Irritable Bowel Syndrome Treatment Drug Market Share by Application (2018-2034)
6.4 Americas Irritable Bowel Syndrome Treatment Drug Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth 2018-2034
7.2 EMEA Irritable Bowel Syndrome Treatment Drug Market Size by Type
7.2.1 EMEA Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018-2023)
7.2.2 EMEA Irritable Bowel Syndrome Treatment Drug Market Size by Type (2024-2034)
7.2.3 EMEA Irritable Bowel Syndrome Treatment Drug Market Share by Type (2018-2034)
7.3 EMEA Irritable Bowel Syndrome Treatment Drug Market Size by Application
7.3.1 EMEA Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018-2023)
7.3.2 EMEA Irritable Bowel Syndrome Treatment Drug Market Size by Application (2024-2034)
7.3.3 EMEA Irritable Bowel Syndrome Treatment Drug Market Share by Application (2018-2034)
7.4 EMEA Irritable Bowel Syndrome Treatment Drug Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth 2018-2034
8.2 China Irritable Bowel Syndrome Treatment Drug Market Size by Type
8.2.1 China Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018-2023)
8.2.2 China Irritable Bowel Syndrome Treatment Drug Market Size by Type (2024-2034)
8.2.3 China Irritable Bowel Syndrome Treatment Drug Market Share by Type (2018-2034)
8.3 China Irritable Bowel Syndrome Treatment Drug Market Size by Application
8.3.1 China Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018-2023)
8.3.2 China Irritable Bowel Syndrome Treatment Drug Market Size by Application (2024-2034)
8.3.3 China Irritable Bowel Syndrome Treatment Drug Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth 2018-2034
9.2 APAC Irritable Bowel Syndrome Treatment Drug Market Size by Type
9.2.1 APAC Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018-2023)
9.2.2 APAC Irritable Bowel Syndrome Treatment Drug Market Size by Type (2024-2034)
9.2.3 APAC Irritable Bowel Syndrome Treatment Drug Market Share by Type (2018-2034)
9.3 APAC Irritable Bowel Syndrome Treatment Drug Market Size by Application
9.3.1 APAC Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018-2023)
9.3.2 APAC Irritable Bowel Syndrome Treatment Drug Market Size by Application (2024-2034)
9.3.3 APAC Irritable Bowel Syndrome Treatment Drug Market Share by Application (2018-2034)
9.4 APAC Irritable Bowel Syndrome Treatment Drug Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Abbvie Inc.
10.1.1 Abbvie Inc. Company Details
10.1.2 Abbvie Inc. Business Overview
10.1.3 Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Introduction
10.1.4 Abbvie Inc. Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
10.1.5 Abbvie Inc. Recent Development
10.2 Bristol Myers Squibb
10.2.1 Bristol Myers Squibb Company Details
10.2.2 Bristol Myers Squibb Business Overview
10.2.3 Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Introduction
10.2.4 Bristol Myers Squibb Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
10.2.5 Bristol Myers Squibb Recent Development
10.3 Roche
10.3.1 Roche Company Details
10.3.2 Roche Business Overview
10.3.3 Roche Irritable Bowel Syndrome Treatment Drug Introduction
10.3.4 Roche Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
10.3.5 Roche Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Details
10.4.2 Johnson & Johnson Business Overview
10.4.3 Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Introduction
10.4.4 Johnson & Johnson Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
10.4.5 Johnson & Johnson Recent Development
10.5 Pfizer Inc.
10.5.1 Pfizer Inc. Company Details
10.5.2 Pfizer Inc. Business Overview
10.5.3 Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Introduction
10.5.4 Pfizer Inc. Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
10.5.5 Pfizer Inc. Recent Development
10.6 Prometheus Laboratories Inc. (Nestle)
10.6.1 Prometheus Laboratories Inc. (Nestle) Company Details
10.6.2 Prometheus Laboratories Inc. (Nestle) Business Overview
10.6.3 Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Introduction
10.6.4 Prometheus Laboratories Inc. (Nestle) Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
10.6.5 Prometheus Laboratories Inc. (Nestle) Recent Development
10.7 Bausch Health
10.7.1 Bausch Health Company Details
10.7.2 Bausch Health Business Overview
10.7.3 Bausch Health Irritable Bowel Syndrome Treatment Drug Introduction
10.7.4 Bausch Health Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
10.7.5 Bausch Health Recent Development
10.8 Takeda Pharmaceutical Ltd
10.8.1 Takeda Pharmaceutical Ltd Company Details
10.8.2 Takeda Pharmaceutical Ltd Business Overview
10.8.3 Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Introduction
10.8.4 Takeda Pharmaceutical Ltd Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
10.8.5 Takeda Pharmaceutical Ltd Recent Development
10.9 Biogen
10.9.1 Biogen Company Details
10.9.2 Biogen Business Overview
10.9.3 Biogen Irritable Bowel Syndrome Treatment Drug Introduction
10.9.4 Biogen Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
10.9.5 Biogen Recent Development
10.10 AstraZeneca
10.10.1 AstraZeneca Company Details
10.10.2 AstraZeneca Business Overview
10.10.3 AstraZeneca Irritable Bowel Syndrome Treatment Drug Introduction
10.10.4 AstraZeneca Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
10.10.5 AstraZeneca Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Irritable Bowel Syndrome Treatment Drug Market Size United States VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Irritable Bowel Syndrome Treatment Drug Market Trends
Table 3. Irritable Bowel Syndrome Treatment Drug Market Drivers
Table 4. Irritable Bowel Syndrome Treatment Drug Market Challenges
Table 5. Irritable Bowel Syndrome Treatment Drug Market Restraints
Table 6. Global Irritable Bowel Syndrome Treatment Drug Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Irritable Bowel Syndrome Treatment Drug Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Irritable Bowel Syndrome Treatment Drug Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Irritable Bowel Syndrome Treatment Drug Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Irritable Bowel Syndrome Treatment Drug, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Irritable Bowel Syndrome Treatment Drug Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Irritable Bowel Syndrome Treatment Drug Revenue Share by Player, 2018-2023
Table 13. Global Irritable Bowel Syndrome Treatment Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Irritable Bowel Syndrome Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Treatment Drug as of 2024)
Table 15. Global Key Players of Irritable Bowel Syndrome Treatment Drug, Headquarters and Area Served
Table 16. Global Key Players of Irritable Bowel Syndrome Treatment Drug, Product and Application
Table 17. Global Key Players of Irritable Bowel Syndrome Treatment Drug, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Irritable Bowel Syndrome Treatment Drug in United States, Ranked by Revenue (2024) & (US$ Million)
Table 20. United States Irritable Bowel Syndrome Treatment Drug Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. United States Irritable Bowel Syndrome Treatment Drug Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Irritable Bowel Syndrome Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Irritable Bowel Syndrome Treatment Drug Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Irritable Bowel Syndrome Treatment Drug Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Irritable Bowel Syndrome Treatment Drug Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Irritable Bowel Syndrome Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Irritable Bowel Syndrome Treatment Drug Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Irritable Bowel Syndrome Treatment Drug Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Irritable Bowel Syndrome Treatment Drug Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Irritable Bowel Syndrome Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Irritable Bowel Syndrome Treatment Drug Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Irritable Bowel Syndrome Treatment Drug Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Irritable Bowel Syndrome Treatment Drug Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Irritable Bowel Syndrome Treatment Drug Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Irritable Bowel Syndrome Treatment Drug Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Irritable Bowel Syndrome Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Irritable Bowel Syndrome Treatment Drug Market Size by Region (2024-2034) & (US$ Million)
Table 51. Abbvie Inc. Company Details
Table 52. Abbvie Inc. Business Overview
Table 53. Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Product
Table 54. Abbvie Inc. Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023) & (US$ Million)
Table 55. Abbvie Inc. Recent Development
Table 56. Bristol Myers Squibb Company Details
Table 57. Bristol Myers Squibb Business Overview
Table 58. Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Product
Table 59. Bristol Myers Squibb Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023) & (US$ Million)
Table 60. Bristol Myers Squibb Recent Development
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Irritable Bowel Syndrome Treatment Drug Product
Table 64. Roche Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Product
Table 69. Johnson & Johnson Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Pfizer Inc. Company Details
Table 72. Pfizer Inc. Business Overview
Table 73. Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Product
Table 74. Pfizer Inc. Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023) & (US$ Million)
Table 75. Pfizer Inc. Recent Development
Table 76. Prometheus Laboratories Inc. (Nestle) Company Details
Table 77. Prometheus Laboratories Inc. (Nestle) Business Overview
Table 78. Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Product
Table 79. Prometheus Laboratories Inc. (Nestle) Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023) & (US$ Million)
Table 80. Prometheus Laboratories Inc. (Nestle) Recent Development
Table 81. Bausch Health Company Details
Table 82. Bausch Health Business Overview
Table 83. Bausch Health Irritable Bowel Syndrome Treatment Drug Product
Table 84. Bausch Health Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023) & (US$ Million)
Table 85. Bausch Health Recent Development
Table 86. Takeda Pharmaceutical Ltd Company Details
Table 87. Takeda Pharmaceutical Ltd Business Overview
Table 88. Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Product
Table 89. Takeda Pharmaceutical Ltd Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023) & (US$ Million)
Table 90. Takeda Pharmaceutical Ltd Recent Development
Table 91. Biogen Company Details
Table 92. Biogen Business Overview
Table 93. Biogen Irritable Bowel Syndrome Treatment Drug Product
Table 94. Biogen Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023) & (US$ Million)
Table 95. Biogen Recent Development
Table 96. AstraZeneca Company Details
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Irritable Bowel Syndrome Treatment Drug Product
Table 99. AstraZeneca Revenue in Irritable Bowel Syndrome Treatment Drug Business (2018-2023) & (US$ Million)
Table 100. AstraZeneca Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Irritable Bowel Syndrome Treatment Drug Product Picture
Figure 2. Global Irritable Bowel Syndrome Treatment Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Irritable Bowel Syndrome Treatment Drug Market Size 2018-2034 (US$ Million)
Figure 4. United States Irritable Bowel Syndrome Treatment Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. United States Irritable Bowel Syndrome Treatment Drug Market Size 2018-2034 (US$ Million)
Figure 6. United States Irritable Bowel Syndrome Treatment Drug Market Share in Global 2018-2034
Figure 7. Irritable Bowel Syndrome Treatment Drug Report Years Considered
Figure 8. Product Picture of Antibiotics
Figure 9. Product Picture of Amino Salicylates
Figure 10. Product Picture of Corticosteroids
Figure 11. Product Picture of Immunomodulators
Figure 12. Product Picture of Others
Figure 13. Global Irritable Bowel Syndrome Treatment Drug Market Share by Type in 2024 & 2034
Figure 14. Global Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018-2034) & (US$ Million)
Figure 15. Global Irritable Bowel Syndrome Treatment Drug Market Share by Type (2018-2034)
Figure 16. United States Irritable Bowel Syndrome Treatment Drug Market Share by Type in 2024 & 2034
Figure 17. United States Irritable Bowel Syndrome Treatment Drug Market Size by Type (2018-2034) & (US$ Million)
Figure 18. United States Irritable Bowel Syndrome Treatment Drug Market Share by Type (2018-2034)
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Specialty Clinics
Figure 21. Product Picture of Other
Figure 22. Global Irritable Bowel Syndrome Treatment Drug Market Share by Application in 2024 & 2034
Figure 23. Global Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018-2034) & (US$ Million)
Figure 24. Global Irritable Bowel Syndrome Treatment Drug Market Share by Application (2018-2034)
Figure 25. United States Irritable Bowel Syndrome Treatment Drug Market Share by Application in 2024 & 2034
Figure 26. United States Irritable Bowel Syndrome Treatment Drug Market Size by Application (2018-2034) & (US$ Million)
Figure 27. United States Irritable Bowel Syndrome Treatment Drug Market Share by Application (2018-2034)
Figure 28. The Top 5 and 10 Largest Companies of Irritable Bowel Syndrome Treatment Drug in the World: Market Share by Irritable Bowel Syndrome Treatment Drug Revenue in 2024
Figure 29. Global Irritable Bowel Syndrome Treatment Drug Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 30. Global Irritable Bowel Syndrome Treatment Drug Market Share by Region (2018-2034)
Figure 31. Americas Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 32. Americas Irritable Bowel Syndrome Treatment Drug Market Share by Type (2018-2034)
Figure 33. Americas Irritable Bowel Syndrome Treatment Drug Market Share by Application (2018-2034)
Figure 34. United States Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 35. Canada Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 36. Mexico Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 37. Brazil Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 38. EMEA Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 39. EMEA Irritable Bowel Syndrome Treatment Drug Market Share by Type (2018-2034)
Figure 40. EMEA Irritable Bowel Syndrome Treatment Drug Market Share by Application (2018-2034)
Figure 41. Europe Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 42. Middle East Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 43. Africa Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 44. China Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 45. China Irritable Bowel Syndrome Treatment Drug Market Share by Type (2018-2034)
Figure 46. China Irritable Bowel Syndrome Treatment Drug Market Share by Application (2018-2034)
Figure 47. APAC Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 48. APAC Irritable Bowel Syndrome Treatment Drug Market Share by Type (2018-2034)
Figure 49. APAC Irritable Bowel Syndrome Treatment Drug Market Share by Application (2018-2034)
Figure 50. Japan Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. South Korea Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 52. China Taiwan Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 53. Southeast Asia Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 54. India Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 55. Abbvie Inc. Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
Figure 56. Bristol Myers Squibb Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
Figure 57. Roche Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
Figure 58. Johnson & Johnson Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
Figure 59. Pfizer Inc. Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
Figure 60. Prometheus Laboratories Inc. (Nestle) Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
Figure 61. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
Figure 62. Takeda Pharmaceutical Ltd Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
Figure 63. Biogen Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
Figure 64. AstraZeneca Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries